GBIO vs ARTV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 08, 2026

GBIO

42.9
AI Score
VS
GBIO Wins

ARTV

31.2
AI Score

Investment Advisor Scores

GBIO

43score
Recommendation
HOLD

ARTV

31score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric GBIO ARTV Winner
Forward P/E 7.874 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -78.9% -100.0% GBIO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 42.9/100 31.2/100 GBIO
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL GBIO

Relative Price Performance (Last 90 Days)

GBIO 1M: -2.4% · 3M: +1.7% ARTV 1M: +19.8% · 3M: -10.0%

Current Technical Phase

GBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 39.7 · Price: $5.34

ARTV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.7% over 20 days), RSI 61

RSI (14): 61.2 · Price: $11.27

Fundamentals Snapshot

Metric GBIO ARTV
Market Cap
Forward P/E -0.7 -4.0
Trailing P/E
Revenue (TTM)
Revenue Growth -0.8% -1.0%
Gross Margin -2.1%
Operating Margin -20.2% 0.0%
EPS -9.37 -3.55
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, GBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.